Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

New Treatment Option Offers Hope for Depression and Chronic Pain: Ketamine Infusion Therapy

Rochester, NY (Newsworthy.ai) Sunday Feb 25, 2024 @ 5:00 PM Eastern —

Upstate Ketamine, an innovative treatment option for patients suffering from psychiatric disorders and chronic pain, has emerged as a significant breakthrough in depression research. An FDA-approved anesthetic with over 50 years of medical use, ketamine is proving to be a game-changer in restoring pathways in the brain and reestablishing communication among nerve cells.

With a strong safety profile and temporary side effects, ketamine infusion therapy has shown remarkable results in improving both function and mood for over 70% of patients. Its rapid relief of depressive symptoms and chronic pain has paved the way for managing treatment-resistant depression, PTSD, fibromyalgia, and other conditions.

Patients seeking ketamine infusion therapy are required to contact the office and undergo an assessment process to determine their eligibility. Upon scheduling their appointment, patients will complete intake forms and be provided a private room for treatment. During the procedure, a small IV catheter will be inserted into the arm, and the infusion will last approximately 40 minutes.

Ketamine infusion therapy offers a fast and highly effective treatment for depression and chronic pain. It provides hope for those who have not responded to traditional treatments, including individuals struggling with suicidal depression.

Embarking on an unparalleled journey of mental health and pain management, ketamine infusion therapy is revolutionizing the way patients can regain control of their lives. Its potential to transform treatment outcomes and provide relief to those who have been previously resistant to other forms of therapy cannot be overlooked.


This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform.™

The reference URL for this press release is located here New Treatment Option Offers Hope for Depression and Chronic Pain: Ketamine Infusion Therapy.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.